Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, has announced that Phil Hagerman, Chairman & CEO, and Sean Whelan, CFO, will present at the upcoming 24th...

Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the third quarter ended September 30, 2015. Cash and investments in marketable securities at September 30, 2015 were...

Sangamo BioSciences, Inc. (Nasdaq: SGMO), a leader in therapeutic genome editing, announced today that non-human primate data from its proprietary In Vivo Protein Replacement Platform (IVPRP™)...

Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced that its management team is scheduled to present at the Canaccord Genuity Medical Technologies and...

Matson, Inc. (NYSE: MATX) announced today that Matt Cox, President and Chief Executive Officer, and Joel Wine, Senior Vice President and Chief Financial Officer, will present an overview of the...